Truist Securities Raises Jazz Pharmaceuticals (JAZZ) Price Target After HERIZON-GEA Trial [Yahoo! Finance]
Is Jazz Pharmaceuticals (JAZZ) Offering An Opportunity After Recent Share Price Pullback [Yahoo! Finance]
Jazz Pharmaceuticals (NASDAQ:JAZZ) had its "buy" rating reaffirmed by analysts at TD Cowen.
Jazz Pharmaceuticals (JAZZ) Is Up 5.1% After Monetizing FDA Voucher And Expanding Oncology Collaboration [Yahoo! Finance]
Jazz Pharmaceuticals price target raised to $235 from $210 at Needham [Yahoo! Finance]